BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Szczepanek J. Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review. World J Clin Oncol 2020; 11(6): 348-369 [PMID: 32855905 DOI: 10.5306/wjco.v11.i6.348]
URL: https://www.wjgnet.com/2218-4333/full/v11/i6/348.htm
Number Citing Articles
1
Luisa Anelli, Antonella Zagaria, Giorgina Specchia, Pellegrino Musto, Francesco Albano. Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as BiomarkersInternational Journal of Molecular Sciences 2021; 22(13): 7156 doi: 10.3390/ijms22137156
2
Sofía Elena Tesolato, Daniel González-Gamo, Ana Barabash, Paula Claver, Sofía Cristina de la Serna, Inmaculada Domínguez-Serrano, Jana Dziakova, Carmen de Juan, Antonio José Torres, Pilar Iniesta. Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass IndexCancers 2023; 15(13): 3324 doi: 10.3390/cancers15133324
3
Neslihan Pinar Ozates, Bakiye Goker Bagca, Duygu Arican, Burak Ascioglu, Burak Durmaz. Elucidating the genetic mechanism of anti-cancer efficacy of prednisolone in acute lymphoblastic leukemia through anti-miRNA treatmentsGene Reports 2025; 39: 102221 doi: 10.1016/j.genrep.2025.102221
4
Aynur KARADAĞ. Comparison of Prognostic miRNA Signature in Patients with Acute and Chronic Myeloid Leukemia by Bioinformatic AnalysisMedical Records 2022; 4(3): 447 doi: 10.37990/medr.1118392
5
Chrysanthy Ikonomidou. Cerebrospinal Fluid Biomarkers in Childhood LeukemiasCancers 2021; 13(3): 438 doi: 10.3390/cancers13030438
6
Kubra A. Coskun, Bercem Yeman Kıyak, Kezban Ucar Cifci, Elif Kadioglu, Nazlican Yurekli, Yusuf Tutar. Involvement of Metabolites and Non-coding RNAs in DiseasesCurrent Pharmaceutical Biotechnology 2023; 24(7): 889 doi: 10.2174/1389201023666220921091240
7
Teresa Mack, Tommaso Gianferri, Alexandra Niedermayer, Klaus-Michael Debatin, Lüder H. Meyer, Vera Muench. Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemiaScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-77733-8
8
Burak Durmaz, Bakiye Goker Bagca, Ozgur Cogulu, Sunde Yilmaz Susluer, Araz Alpay, Serap Aksoylar, Cumhur Gunduz, Zhenbo Xu. [Retracted] Antileukemic Effects of Anti‐miR‐146a, Anti‐miR‐155, Anti‐miR‐181a, and Prednisolone on Childhood Acute Lymphoblastic LeukemiaBioMed Research International 2021; 2021(1) doi: 10.1155/2021/3207328
9
Rastee H. Saeed, Zirak Faqe Ahmed Abdulrahman, Dara K. Mohammad. Exploring the interplay between microRNA expression and DNA mutation analysis in AML patientsSaudi Journal of Biological Sciences 2024; 31(7): 104027 doi: 10.1016/j.sjbs.2024.104027
10
Mingliang Rao, Wenna Luo, Caiju Luo, Baojing Wu, Tiantian Xu, Ziqian Wei, Haolan Deng, Kejing Li, Dunhua Zhou. Prognostic factors and outcomes in pediatric acute myeloid leukemia: a comprehensive bibliometric analysis of global research trendsFrontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1466818
11
Ka-Won Kang, Jeong-An Gim, Sunghoi Hong, Hyun Koo Kim, Yeonho Choi, Ji-ho Park, Yong Park, Andres Mauricio Acevedo-Melo. Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkersPLOS ONE 2024; 19(8): e0306962 doi: 10.1371/journal.pone.0306962
12
Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn. MicroRNA as a Potential Therapeutic Molecule in CancerCells 2022; 11(6): 1008 doi: 10.3390/cells11061008
13
Amani Dhiflaoui, Sana Mahjoub, Vera Chayeb, Bechir Achour, Saoussen Chouchen, Hassen Ben Abdennebi, Touhami Mahjoub, Wassim Y. Almawi. miR-146a, miR-196a2, miR-499, and miR-149 linked with susceptibility to acute lymphoblastic leukemia: A case-control study in TunisiaGene 2022; 834: 146648 doi: 10.1016/j.gene.2022.146648
14
Eleni Tsotridou, Elisavet Georgiou, Athanasios Tragiannidis, Chrysostomos Avgeros, Georgios Tzimagiorgis, Maria Lambrou, Eugenia Papakonstantinou, Assimina Galli‑Tsinopoulou, Emmanouel Hatzipantelis. miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemiaOncology Letters 2023; 27(2) doi: 10.3892/ol.2023.14204
15
Zsuzsanna Gaál. Implication of microRNAs in Carcinogenesis with Emphasis on Hematological Malignancies and Clinical TranslationInternational Journal of Molecular Sciences 2022; 23(10): 5838 doi: 10.3390/ijms23105838
16
Elena Esperanza‐Cebollada, Soledad Gómez‐González, Sara Perez‐Jaume, Nerea Vega‐García, Clara Vicente‐Garcés, Mercè Richarte‐Franqués, Susana Rives, Albert Català, Montserrat Torrebadell, Mireia Camós. A miRNA signature related to stemness identifies high‐risk patients in paediatric acute myeloid leukaemiaBritish Journal of Haematology 2023; 202(1): 96 doi: 10.1111/bjh.18746
17
Dawid Szwedowski, Joanna Szczepanek, Łukasz Paczesny, Przemysław Pękała, Jan Zabrzyński, Jacek Kruczyński. Genetics in Cartilage Lesions: Basic Science and Therapy ApproachesInternational Journal of Molecular Sciences 2020; 21(15): 5430 doi: 10.3390/ijms21155430
18
Andrea Rzepiel, Anna Horváth, Nóra Kutszegi, András Gézsi, Judit C. Sági, Laura Almási, Bálint Egyed, Péter Lőrincz, Tamás Visnovitz, Gábor T. Kovács, Csaba Szalai, Ágnes F. Semsei, Dániel J. Erdélyi. MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemiaMolecular and Cellular Probes 2023; 67: 101893 doi: 10.1016/j.mcp.2023.101893
19
Karolina Joanna Ziętara, Jan Lejman, Katarzyna Wojciechowska, Monika Lejman. The Importance of Selected Dysregulated microRNAs in Diagnosis and Prognosis of Childhood B-Cell Precursor Acute Lymphoblastic LeukemiaCancers 2023; 15(2): 428 doi: 10.3390/cancers15020428
20
Albert T. Anastasio, Samuel B. Adams. Cartilage InjuriesFoot and Ankle Clinics 2024; 29(2): 357 doi: 10.1016/j.fcl.2023.08.002
21
Amirata Mohseni, Fatemeh Salehi, Samaneh Rostami, Kaveh Hadiloo, Mehrdad Hashemi, Zahra Baridjavadi, Fatemeh Ahangari, Najibeh Karami, Fatemeh Samani, Safa Tahmasebi, Najma Farahani, Afshin Taheriazam. Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignanciesStem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-024-04125-0